Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Date of authorisation: 25/10/2012, Revision: 38, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 20 March 2026 - 14:28

Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Date of authorisation: 25/10/2012, Revision: 38, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/adcetris

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters